NCT07713251 Supporting Adolescent Alcohol Treatment With Computer-Based ('Path180') Skills Training
| NCT ID | NCT07713251 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Brown University |
| Condition | Alcohol Use Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 112 participants |
| Start Date | 2026-07-07 |
| Primary Completion | 2028-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 112 participants in total. It began in 2026-07-07 with a primary completion date of 2028-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This 8-week clinical trial will test a computer-based skills training program called Path180 with 112 adolescents aged 13 to 19 who are receiving mental health counseling or outpatient substance use treatment. Participants will be randomly assigned to either standard treatment (treatment as usual) or standard treatment plus Path180. The study will use ecological momentary assessment (EMA) to closely track how Path180 may influence the use of CBT skills and clinical outcomes in daily life. The goal is to help make evidence-based treatment more accessible for underserved youth in the early stages of alcohol use disorder.
Eligibility Criteria
Inclusion Criteria: * Ages 13 to 19 years, inclusive; we will exclude children \< 13 due to diversity across adolescence and youths \> 19 because our focus is teenagers * Seeking/receiving mental health counseling and/or outpatient substance use disorder treatment at Bradley Hospital or another national clinic/treatment service * Self-reported alcohol use in the past year * Meets criteria for a current DSM-5 alcohol use disorder assessed using the Schedule for Affective Disorders and Schizophrenia for School-Age Children: Present and Lifetime Version (K-SADS) * Able to understand written and oral instructions in English, communicate understanding of the consent/assent form, and provide written informed consent/assent * Complete all assessments required at screening. * Provide contact information of someone, such as a parent or other family member, who may be able to contact the participant in case of a missed study appointment or follow-up assessment. * Agree to the schedule of visits, verbally acknowledge that he/she/they will be able to attend each scheduled visit, participate in phone visits and that he/she/they does not have any already scheduled events or a job that may substantially interfere with study participation. * If younger than 18 years, permission from the minor's legal authorized representative (e.g., caregiver, parent) is required, herein referred to as parent permission. Exclusion Criteria: * Current significant alcohol withdrawal symptoms (score \> 10) on the Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-AR); those with current significant alcohol withdrawal may be re-screened after stabilization * DSM-5 criteria for a severe SUD besides alcohol, cannabis and tobacco * Psychosis NOTE: Prospective participants diagnosed with psychiatric disorders not specifically excluded above may be included at the discretion of the principal investigator as long as the concurrent treatment for the comorbid psychiatric condition does not compromise the study integrity by virtue of its type, duration, or intensity.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07713251 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 19 Years, studying Alcohol Use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07713251 currently recruiting?
Yes, NCT07713251 is actively recruiting participants. Contact the research team at Robert_Miranda_Jr@brown.edu for enrollment information.
Where is the NCT07713251 trial being conducted?
This trial is being conducted at Providence, United States.
Who is sponsoring the NCT07713251 clinical trial?
NCT07713251 is sponsored by Brown University. The trial plans to enroll 112 participants.